EUVIMEDScopri EUVIMED
Crossref

Metabolomic and Lipidomic Characterization of Meningioma Grades Using LC–HRMS and Machine Learning

Hoda Safari Yazd, Sina Feizbakhsh Bazargani, Garrett Fitzpatrick, Richard A Yost iD, Jesse Kresak, Timothy J Garrett iD

Journal of the American Society for Mass Spectrometry · 2023-10-04 · 34 (10) · 2187-2198

DOI: 10.1021/jasms.3c00158 ↗

At a glance

Journal article in Journal of the American Society for Mass Spectrometry, published online on 2023-09-14. Written by Hoda Safari Yazd and 5 co-authors. Institution: Department of Chemistry, University of Florida, Gainesville, Florida 32610, United States. Major MEDLINE topics: Meningioma, Meningeal Neoplasms, Brain Neoplasms. Cited 17 times so far (Crossref); 54 references. Funded by: University of Florida.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Meningiomas are among the most common brain tumors that arise from the leptomeningeal cover of the brain and spinal cord and account for around 37% of all central nervous system tumors. According to the World Health Organization, meningiomas are classified into three histological subtypes: benign, atypical, and anaplastic. Sometimes, meningiomas with a histological diagnosis of benign tumors show clinical characteristics and behavior of aggressive tumors. In this study, we examined the metabolomic and lipidomic profiles of meningioma tumors, focusing on comparing low-grade and high-grade tumors and identifying potential markers that can discriminate between benign and malignant tumors. High-resolution mass spectrometry coupled to liquid chromatography was used for untargeted metabolomics and lipidomics analyses of 85 tumor biopsy samples with different meningioma grades. We then applied feature selection and machine learning techniques to find the features with the highest information to aid in the diagnosis of meningioma grades. Three biomarkers were identified to differentiate low- and high-grade meningioma brain tumors. The use of mass-spectrometry-based metabolomics and lipidomics combined with machine learning analyses to prospect and characterize biomarkers associated with meningioma grades may pave the way for elucidating potential therapeutic and prognostic targets.

Subjects

MeSH terms (MEDLINE)

MeningiomaMeningeal NeoplasmsBrain NeoplasmsHumansLipidomicsBiomarkersMachine Learning

Author keywords

Brain TumorLipidomicsMachine LearningMass SpectrometryMeningiomaMetabolomics

Substances

Biomarkers

Authors and institutions

  • Department of Chemistry, University of Florida, Gainesville, Florida 32610, United States.
  • Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida 32610, United States.

ORCID profiles: Richard A Yost, Timothy J Garrett

Funding

  • University of Florida

Cite

APA

Safari Yazd, H., Bazargani, S. F., Fitzpatrick, G., Yost, R. A., Kresak, J., & Garrett, T. J. (2023). Metabolomic and Lipidomic Characterization of Meningioma Grades Using LC–HRMS and Machine Learning. Journal of the American Society for Mass Spectrometry, 34(10), 2187-2198. https://doi.org/10.1021/jasms.3c00158

Vancouver

Safari Yazd H, Bazargani SF, Fitzpatrick G, Yost RA, Kresak J, Garrett TJ. Metabolomic and Lipidomic Characterization of Meningioma Grades Using LC–HRMS and Machine Learning. Journal of the American Society for Mass Spectrometry. 2023;34(10):2187-2198. doi:10.1021/jasms.3c00158

BibTeX
@article{SafariYazd2023,
  author = {Safari Yazd, Hoda and Bazargani, Sina Feizbakhsh and Fitzpatrick, Garrett and Yost, Richard A and Kresak, Jesse and Garrett, Timothy J},
  title = {Metabolomic and Lipidomic Characterization of Meningioma Grades Using LC–HRMS and Machine Learning},
  journal = {Journal of the American Society for Mass Spectrometry},
  year = {2023},
  volume = {34},
  number = {10},
  pages = {2187--2198},
  doi = {10.1021/jasms.3c00158}
}
Start for free →